{"id":"https://openalex.org/W3097451275","doi":"https://doi.org/10.1182/blood-2020-141042","title":"Base Excision Repair and Homologous Recombination Pathway Intermediates Drive Genomic Instability and Evolution in Myeloma","display_name":"Base Excision Repair and Homologous Recombination Pathway Intermediates Drive Genomic Instability and Evolution in Myeloma","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3097451275","doi":"https://doi.org/10.1182/blood-2020-141042","mag":"3097451275"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-141042","doi":"https://doi.org/10.1182/blood-2020-141042","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141042","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084310044","display_name":"Chengcheng Liao","orcid":"https://orcid.org/0000-0003-0408-6684","observed_orcids":["https://orcid.org/0000-0003-0408-6684"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chengcheng Liao","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112389374","display_name":"Srikanth Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srikanth Talluri","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103420970","display_name":"Subodh Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subodh Kumar","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036264384","display_name":"Leutz Buon","orcid":"https://orcid.org/0009-0000-5990-1936","observed_orcids":["https://orcid.org/0009-0000-5990-1936"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leutz Buon","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103176292","display_name":"Jiangning Zhao","orcid":"https://orcid.org/0000-0003-3830-2672","observed_orcids":["https://orcid.org/0000-0003-3830-2672"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiangning Zhao","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078948384","display_name":"Lakshmi B. Potluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi B. Potluri","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056254084","display_name":"RAO H. PRABHALA","orcid":"https://orcid.org/0000-0002-6375-0437","observed_orcids":["https://orcid.org/0000-0002-6375-0437"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rao Prabhala","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0812,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.36359001,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"27","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.023099999874830246,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.9240000247955322},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9589999914169312},{"id":"https://openalex.org/keywords/base-excision-repair","display_name":"base excision repair","score":0.9959999918937683},{"id":"https://openalex.org/keywords/apex1","display_name":"APEX1","score":0.8579999804496765},{"id":"https://openalex.org/keywords/apex2","display_name":"APEX2","score":0.9890000224113464},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.9800000190734863},{"id":"https://openalex.org/keywords/p73","display_name":"p73","score":0.9390000104904175},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.7720000147819519},{"id":"https://openalex.org/keywords/blm","display_name":"BLM","score":0.9789999723434448},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.8090000152587891},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.7639999985694885},{"id":"https://openalex.org/keywords/transcriptional-regulation","display_name":"transcriptional regulation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7770000100135803},{"id":"https://openalex.org/keywords/protein-dna-interactions","display_name":"protein-DNA interactions","score":0.4659999907016754},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.8173682689666748},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.7904742956161499},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.685204029083252},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5735293626785278},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5530027151107788},{"id":"https://openalex.org/C134320426","wikidata":"https://www.wikidata.org/wiki/Q901026","display_name":"Chromatin immunoprecipitation","level":5,"score":0.5469850897789001},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.520153820514679},{"id":"https://openalex.org/C187206112","wikidata":"https://www.wikidata.org/wiki/Q3113091","display_name":"Base excision repair","level":4,"score":0.4790250360965729},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4340311288833618},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4095410704612732},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.36228811740875244},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.34781181812286377},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.3306256830692291},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1764964759349823}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-141042","doi":"https://doi.org/10.1182/blood-2020-141042","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141042","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591224296","https://openalex.org/W4387003562","https://openalex.org/W2893714831","https://openalex.org/W2289841937","https://openalex.org/W3095012800","https://openalex.org/W2577420464","https://openalex.org/W2564201286","https://openalex.org/W4293045213","https://openalex.org/W2590532285","https://openalex.org/W2921201565"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1],"(MM)":[2],"cells":[3,26,245,367,408,433,445,454,469,477,527],"demonstrate":[4],"significant":[5],"genomic":[6,12,61,318,412,588,599],"instability":[7,62,413],"with":[8,112,120,285,308,434,455,470,496,531],"acquisition":[9],"of":[10,45,65,126,182,192,221,228,237,251,283,291,300,348,394,426,452,465,508,519,522,550,608,642],"new":[11],"events":[13],"over":[14],"time.":[15],"In":[16,569],"an":[17,573,639],"effort":[18],"to":[19,27,31,60,133,313,392,556,563,605],"decipher":[20],"the":[21,73,80,158,164,190,218,226,235,247,281,289,298,369,396,463,506,517,609],"pathways":[22],"utilized":[23],"by":[24,265,275,303,321,374,384,416,421,439,448,478],"MM":[25,241,354,512],"genomically":[28],"evolve":[29],"and":[30,63,91,109,131,137,162,184,199,243,267,288,295,398,411,487,524,541,548,584,601,611],"acquire":[32],"proliferative":[33],"advantage":[34],"as":[35,37,325,327,355,357],"well":[36,326,356],"develop":[38],"drug":[39,66],"resistance,":[40,67],"we":[41,68,95,147,239,500,571],"have":[42,69,96,279,332],"investigated":[43,97,516],"role":[44,227],"various":[46],"pathway":[47,340,581],"intermediates.":[48],"Based":[49],"on":[50,79,189,638],"our":[51],"prior":[52],"results":[53,593],"showing":[54],"elevated":[55],"homologous":[56],"recombination":[57],"(HR)":[58],"contributing":[59],"development":[64],"further":[70,143,333],"studied":[71],"RAD51,":[72],"key":[74,339],"HR":[75,114,140,194,222,329,379,397,410,547],"gene.":[76],"Also":[77],"based":[78],"dysfunctional":[81],"base":[82,399],"excision":[83,400],"repair":[84,580],"(BER)":[85],"that":[86,106,212,258,297,346,388],"can":[87],"increase":[88,138,370],"DNA":[89,170,276,579],"damage":[90],"dysregulate":[92],"genome":[93],"stability,":[94],"apurinic/apyrimidinic":[98],"endonuclease":[99],"(APEX)1/2":[100],"in":[101,116,139,217,230,234,246,342,353,365,371,405,443,475,511,590,615,634,654],"MM.":[102,117,343,591,616],"We":[103,278,331,344,514],"first":[104,159],"observed":[105,205],"both":[107,395],"APEX1":[108,118,183,213,229,284,304,322,349,523,566,583],"APEX2":[110],"interact":[111],"multiple":[113],"genes":[115,196],"interacts":[119],"P73,":[121],"a":[122,254,557],"known":[123],"transcriptional":[124,135,232],"regulator":[125],"RAD51":[127,129,286,301,385,390,422,435,456,471,488,538,564,585],"at":[128],"promoter,":[130],"contributes":[132,391],"its":[134,612],"upregulation":[136],"activity.":[141],"To":[142,224],"extend":[144],"these":[145,337,366,444,453],"observations,":[146],"conducted":[148,268],"sequential":[149],"chromatin":[150],"immunoprecipitation":[151],"(ChIP-reChIP)":[152],"assays,":[153,177],"using":[154,178,271,293],"MM.1S":[155],"cells.":[156,513],"For":[157],"ChIP,":[160],"anti-APEX1":[161,272],"for":[163,174,206,492,546],"reChIP":[165],"anti-p73":[166],"antibody":[167,273],"was":[168,172,186,203,382,419],"used.":[169],"recovered":[171],"used":[173],"real-time":[175],"Q-PCR":[176,294],"promoter-specific":[179],"primers.":[180],"Colocalization":[181],"p73":[185],"thus":[187],"confirmed":[188,280,334],"promoters":[191],"three":[193],"related":[195],"(RAD51,":[197],"BRCA1":[198],"BLM),":[200],"whereas":[201,450],"interaction":[202,282,483],"not":[204],"CDK2":[207],"promoter.":[208],"These":[209,592],"data":[210,312],"suggested":[211],"may":[214],"be":[215,314],"involved":[216],"overall":[219],"regulation":[220,233],"machinery.":[223],"investigate":[225],"genomewide":[231],"context":[236],"HR,":[238],"cultured":[240],"(H929":[242],"MM.1S)":[244],"presence":[248],"or":[249,534,539,565,644],"absence":[250],"camptothecin":[252],"(CPT;":[253],"topoisomerase":[255],"I":[256],"inhibitor":[257,436,457,472],"induces":[259],"DSBs":[260],"which":[261,381,418],"are":[262],"mainly":[263],"repaired":[264],"HR),":[266],"ChIP":[269],"assays":[270],"followed":[274],"sequencing.":[277],"promoter":[287,302],"impact":[290,518],"CPT,":[292],"observe":[296,345,501],"occupancy":[299],"increases":[305,350,505],"following":[306,542],"treatment":[307,425,451,464],"CPT.":[309],"The":[310,424],"sequencing":[311],"presented":[315],"will":[316],"identify":[317],"regions":[319],"occupied":[320],"under":[323],"spontaneous":[324],"modulated":[328],"conditions.":[330],"interrelationship":[335],"between":[336,484,576],"two":[338],"intermediates":[341],"overexpression":[347],"abasic":[351,372],"sites":[352,373],"another":[358],"cancer":[359],"(esophageal":[360],"adenocarcinoma)":[361],"cells,":[362],"while":[363],"RAD51-knockdown":[364],"prevents":[368],"APEX1.":[375],"Similarly,":[376,462],"APEX1-overexpression":[377,442],"increased":[378,409,446,559],"activity":[380],"prevented":[383],"inhibition,":[386],"indicating":[387],"APEX-induced":[389],"dysregulation":[393],"repair.We":[401],"also":[402,489,515],"demonstrated":[403],"thatAPEX-overexpression":[404],"normal":[406,431],"hematopoietic":[407],"(as":[414],"assessed":[415],"micronuclei),":[417],"reversed":[420,459],"inhibitor.":[423],"control":[427,532,606],"plasmid":[428],"transfected":[429],"CD138+":[430],"plasma":[432],"reduced":[437,473],"micronuclei":[438,447,474],"53.5%.":[440],"Importantly,":[441],"34.7%,":[449],"completely":[458],"this":[460],"increase.":[461],"bone":[466],"marrow/stromal":[467],"(HS5)":[468],"APEX1-overexpressing":[476],"55%.":[479],"This":[480],"unique":[481],"functional":[482],"APEX":[485,494],"nuclease":[486],"provides":[490],"rationale":[491],"combining":[493],"inhibitors":[495],"chemotherapeutic":[497,509],"agents.":[498],"Consistently,":[499],"thatAPEX":[502],"inhibition":[503,567],"synergistically":[504],"efficacy":[507],"agents":[510],"simultaneous":[520],"suppression":[521],"RAD51.":[525],"Cancer":[526],"(FLO-1)":[528],"were":[529],"transduced":[530],"shRNAs":[533],"those":[535],"targeting":[536],"APEX1,":[537],"both,":[540],"puromycin":[543],"selection":[544],"evaluated":[545],"evidence":[549],"apoptosis.":[551],"Combined":[552],"RAD51/APEX1":[553],"knockdown":[554],"led":[555],"significantly":[558],"apoptosis":[560],"(P=0.0003),":[561],"relative":[562],"alone.":[568],"summary,":[570],"report":[572],"interesting":[574],"interaction/crosstalk":[575],"2":[577],"major":[578],"intermediates,":[582],"recombinase,":[586],"driving":[587,598],"evolution":[589,607],"provide":[594],"insight":[595],"into":[596],"processes":[597],"progression":[600],"suggest":[602],"possible":[603],"avenues":[604],"disease":[610],"clinical":[613],"consequences":[614],"Disclosures":[617],"Munshi:":[618],"Janssen:":[619],"Consultancy;":[620,622,624,626,628,658,660],"Amgen:":[621],"Legend:":[623],"Adaptive:":[625],"BMS:":[627],"OncoPep:":[629],"Consultancy,":[630],"Current":[631,651],"equity":[632,652],"holder":[633,653],"private":[635,655],"company,":[636],"Membership":[637],"entity's":[640],"Board":[641],"Directors":[643],"advisory":[645],"committees,":[646],"Patents":[647],"&":[648],"Royalties;":[649],"C4:":[650],"company;":[656],"AbbVie:":[657],"Karyopharm:":[659],"Takeda:":[661],"Consultancy.":[662]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-11-09T00:00:00"}